Approvals/TGA/COMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial

Approved

STANDARD

COMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0a6ba42b2c42ddb9
Product Name: COMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial
Artg Id: 506507
Artg Name: COMIRNATY LP.8.1 (SARS-CoV-2 spike protein (mRNA) LP.8.1) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection multidose vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2025-10-01
Registration Type: Medicine
Therapeutic Good Type: Medicines
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/7828c8e436a60b0dd373553bdb355954.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Oct 4, 2025

Approval ID

0a6ba42b2c42ddb9

Type

Standard